1. Home
  2. VLTO vs WAT Comparison

VLTO vs WAT Comparison

Compare VLTO & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veralto Corp

VLTO

Veralto Corp

HOLD

Current Price

$102.29

Market Cap

24.5B

Sector

Industrials

ML Signal

HOLD

Logo Waters Corporation

WAT

Waters Corporation

HOLD

Current Price

$384.83

Market Cap

22.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLTO
WAT
Founded
2023
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.5B
22.5B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
VLTO
WAT
Price
$102.29
$384.83
Analyst Decision
Buy
Buy
Analyst Count
9
15
Target Price
$113.25
$390.67
AVG Volume (30 Days)
1.8M
563.9K
Earning Date
02-03-2026
02-11-2026
Dividend Yield
0.51%
N/A
EPS Growth
12.64
3.82
EPS
3.65
10.88
Revenue
$5,452,000,000.00
$3,105,638,000.00
Revenue This Year
$8.28
$7.96
Revenue Next Year
$5.74
$6.32
P/E Ratio
$28.03
$35.38
Revenue Growth
6.15
6.90
52 Week Low
$83.87
$275.05
52 Week High
$110.11
$423.56

Technical Indicators

Market Signals
Indicator
VLTO
WAT
Relative Strength Index (RSI) 57.43 52.12
Support Level $99.47 $372.17
Resistance Level $101.75 $385.69
Average True Range (ATR) 1.71 8.35
MACD 0.35 -2.23
Stochastic Oscillator 83.26 45.74

Price Performance

Historical Comparison
VLTO
WAT

About VLTO Veralto Corp

Veralto is a diversified industrial firm organized into two segments, water quality as well as product quality and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.2 billion in revenue in 2024.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: